Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

CUSIP: 92686J106

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
113,177,462
Total 13F shares
44,443
Share change
+3,165
Total reported value
$65,000
Price per share
$1.53
Number of holders
6
Value change
-$25,998
Number of buys
5
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2016

As of 31 Mar 2016, Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,443 shares. The largest 6 holders included VANGUARD GROUP INC, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and BlackRock Fund Advisors. This page lists 6 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.